One mechanism that might explain how this effect is mediated was explored in a bladder cancer model in which metformin was able to inhibit stem cell multiplication by reducing COX-2-mediated PGE2 and following STAT3 activation both in mouse bladder cancer and bladder cancer cell lines [89]. The gene discussed is STAT3; the disease is urinary bladder carcinoma.